Adult life after surviving lymphoma in childhood

Supportive Care in Cancer

Volumn 16, Issue 4, 2008, Pages 339-345

  Von Der Weid, Nicolas X ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Adult life; Children; Late effects; Lymphoma; Pediatric

Indexed keywords

ALKYLATING AGENT; ANTHRACYCLINE; BLEOMYCIN; CARMUSTINE; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; STEROID; VINCRISTINE;

ARTERY DISEASE; AVASCULAR NECROSIS; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOMYOPATHY; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM TUMOR; CHILDHOOD CANCER; DEPRESSION; DRUG INDUCED DISEASE; EARLY MENOPAUSE; ENDOCARDIAL DISEASE; HEART INFARCTION; HODGKIN DISEASE; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; INFERTILITY; LEUKEMIA; LUNG FIBROSIS; MYELODYSPLASTIC SYNDROME; MYOCARDIAL DISEASE; NEUROLOGICAL COMPLICATION; NONHODGKIN LYMPHOMA; OSTEOPENIA; OSTEOPOROSIS; PERICARDIAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOMATIC DISORDER; QUALITY OF LIFE; RADIATION INJURY; REVIEW; SKIN CANCER; THYROID CANCER; THYROID NODULE; TOOTH DISEASE;

ADULT; CHILD; COGNITION DISORDERS; ENDOCRINE SYSTEM; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; SURVIVORS;

EID: 43449092273     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-007-0369-x     Document Type: Review

References (41)

1. Bhatia S, Robison LL, Meadows AT, LESG Investigators (2001) High risk of second malignant neoplasms (SMN) continues with extended follow-up of childhood Hodgkin's disease (HD) cohort: report from the Late Effects Study Group. Blood 98:768a
2. Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, Bash RO, Behm FG, Camitta BM, Pui CH, Raimondi SC, Relling MV (2002) Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies. Pharmacogenetics 12:605-611
3. Byrne J, Fears TR, Gail MH (1992) Early menopause in long-term survivors of cancer during adolescence. Am J Obstetr Gynecol 166:788-793
4. Chapman RM, Sutcliffe SB, Malpas JS (1979) Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function. J Am Med Assoc 242:1877-1881
5. Chow LML, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, Manson D, Bross A, Doyle JJ, Danjoux C, Greenberg ML (2006) Survival and late effects in children with Hodgkin's lymphoma treated with MOP/ABV and low-dose, extended-field irradiation. J Clin Oncol 24:5735-5741
6. de Cunha MF, Meistrich ML, Fuller LM (1984) Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy. J Clin Oncol 2:571-578
7. Donaldson SS, Kaplan HS (1982) Complications of treatment of Hodgkin's disease in children. Cancer Treat Rep 66:977-983
8. Dreyer ZE, Blatt J, Bleyer A (2002) Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG (eds) Principles and Practice of Pediatric Oncology. vol. 4. Lippincott and Wilkins, Philadelphia, pp 1431-1461
9. Felix CA (1998) Secondary leukemias induced by topoisomerase-targeted drugs. Biochim Biophys Acta 1400:233-255
10. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NK, Lovett BD, Nowell PC, Blair LA, Rebbeck TR (1998) Association of CYP3A4 genotype with treatment-related leukemia. Proc Natl Acad Sci USA 95:13176-13181
11. Green DM, Zevon MA, Rock KM, Chavez F (2002) Fatigue after treatment for Hodgkin's disease during childhood or adolescence. Proc Am Soc Clin Oncol 21:396a
12. Hancock SL, Donaldson SS, Hoppe RT (1993) Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11:1199-1203
13. Hertzberg H, Huk WJ, Ueberall MA, Langer T, Meier W, Dopfer R, Skalej M, Lackner H, Bode U, Janssen G Zintl F, Beck JD (1997) CNS late effects after ALL therapy in childhood. Part I: neuroradiological findings in long-term survivors of childhood ALL. An evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. Med Ped Oncol 28:387-400
14. Horning SJ, Hoppe RT, Kaplan HS (1981) Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 304:1377-1381
15. Kaldor JM, Day NE, Clarke EA, van Leeuwen FE, Henry-Amar M, Fiorentino MV, Bell J, Pedersen D, Band P, Assouline D, Koch M, Choi W, Prior P, Blair V, Langmark F, Pompe Kern V, Neal F, Peters D, Pfeiffer R, Karjalainen S, Cuzick J, Sutcliffe SB, Somers R, Pellac-Cosset B, Papagallo GL, Fraser P, Storm H, Stovall M (1990) Leukemia following Hodgkin's disease. New Engl J Med 322:7-13
16. Katz JA, Pollock BH, Jacaruso D, Morad A (1993) Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia. J Pediatr 123:546-552
17. Kremer LCM, van Dalen EC, Offringa M, Otenkamp J, Voute PA (2001) Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol 19:191-196
18. Kremer LCM, van der Pal HJH, Offringa M, van Dalen EC, Voute PA (2002) Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. Ann Oncol 13:819-829
19. Le Floch O, Donaldson SS, Kaplan HS (1976) Pregnancy following oophoropexy in total node irradiation in women with Hodgkin's disease. Cancer 38:2263-2265
20. Lin HMJ, Teitell MA (2005) Second malignancy after treatment of pediatric Hodgkin's disease. J Pediatr Hematol Oncol 27:28-36
21. Mackie EJ, Radford M, Shalet SM (1996) Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 7:74-78
22. Metayer C, Lynch CF, Clarke EA, Glimelius B, Storm H, Pukkala E, Joensuu T, van Leeuwen FE, van't Veer MB, Curtis RE, Holowaty EJ, Andersson M, Wiklund T, Gospodarowicz M, Travis LB (2000) Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18:2435-2443
23. Mulhern RK, Reddick WE, Palmer SL, Glass JO, Elkin TD, Kun LE, Taylor J, Langston J, Gajjar A (1999) Neurocognitive deficits in medulloblastoma survivors and white matter loss. Ann Neurol 46:834-841
24. Naoe T, Takeyama K, Yogozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-Nai L, Kamada N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R (2000) Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 6:4091-4095
25. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 93:618-629
26. Ochs J, Mulhern R, Fairclough D, Parvey L, Whitaker J, Ch'ien L, Mauer A, Simone J (1991) Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: a prospective study. J Clin Oncol 9:145-151
27. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, Vik TA, Inskip PD, Robison LL (2003) Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 21:1359-1365
28. Ortin TT, Shostak CA, Donaldson SS (1990) Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. Int J Radiat Oncol Biol Phys 19:873-880
29. Pui CH, Relling MV, Rivera GK, Hancock ML, Raimondi SC, Heslop HE, Santana VM, Ribeiro RC, Sandlung JT, Mahmoud HH, Evans WE, Crist WM, Krance RA (1995) Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases. Leukemia 9:1990-1996
30. Relling MV, Rubnitz JE, Rivera GK, Boyett JM, Hancock ML, Felix CA, Kun LE, Walter AW, Evans WE, Pui CH (1999) High incidence of secondary brain tumors after radiotherapy and antimetabolites. Lancet 354:34-39
31. Robison LL, Mertens AC, Boice JD, Breslow NE, Donaldson SS, Green DM, Li FP, Meadows AT, Mulvihill JJ, Neglia JP, Nesbit ME, Packer RJ, Potter JD, Sklar CA, Smith MA, Stovall M, Strong LC, Yasui Y, Zeltzer LK (2002) Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol 38:229-239
32. Robison LL, Bathia S (2003) Late effects among survivors of leukemia and lymphoma during childhood and adolescence. Br J Haematol 122:345-359
33. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR (1996) Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total body irradiation and bone marrow transplantation. Blood 87:3045-3052
34. Shamberger RC, Sherins RJ, Rosenberg SA (1981) The effects of post-operative adjuvant chemotherapy and radiotherapy on testicular function in men undergoing treatment for soft-tissue sarcoma. Cancer 47:2368-2374
35. Sklar C, Mertens A, Walter A, Mitchell D, Nesbit M, O'Leary M, Hutchinson R, Meadows AT, Robison L (1993) Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr 123:59-64
36. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S, Robison L (2000) Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85:3227-3232
37. Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D (1999) Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17:569-577
38. Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA (1988) Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 318:76-81
39. von der Weid NX (2001) Late effects in long-term survivors of ALL in childhood: experiences from the SPOG Late Effects Study. Swiss Med Wkly 131:180-187
40. von der Weid NX, Mosimann I, Hirt A, Wacker P, Nenadov Beck M, Imbach P, Caflisch U, Niggli F, Feldges A, Wagner HP (2003) Intellectual outcome in children and adolescents with acute lymphoblastic leukemia treated with chemotherapy alone: age- and sex-related differences. Eur J Cancer 39:359-365
41. Zebrack BJ, Zeltzer LK, Whitton J, Mertens AC, Odom L, Berkow R, Robison LL (2002) Psychological outcomes in long-term survivors of childhood leukemia, Hodgkin's disease and non-Hodgkin's lymphoma: a report from the Childhood Cancer Survivor Study. Pediatrics 110:42-52